Neonatal Hypercalcemia Secondary to Subcutaneous Fat Necrosis Successfully Treated with Pamidronate: A Case Series and Literature Review

Abstract

Subcutaneous fat necrosis (SCFN) is a noninfectious panniculitis that occurs in term infants who experience significant distress in the 1st weeks of life, including hypoxic ischemic encephalopathy (HIE). Since the introduction of therapeutic hypothermia for HIE, there have been a few published case reports of SCFN, following this modality of treatment. Although, most cases of SCFN resolve spontaneously, SCFN may be associated with hypercalcemia, which may sometimes reach dangerous levels. Approaches used for the management of this potentially life-threatening condition, include hyperhydration, calciuric diuretics, corticosteroids, and in more resistant cases pamidronate, a bisphosphonate. We report our experience on the use of pamidronate in two cases of severe hypercalcemia associated with SCFN following therapeutic hypothermia for HIE. We believe that with increasing use of therapeutic hypothermia for HIE, clinicians are likely to encounter this condition more frequently.

Keywords

hypercalcemia - therapeutic hypothermia - newborn - pamidronate - subcutaneous fat necrosis

• References

• 1 Akin MA, Akin L, Coban D, Akcakus M, Balkanli S, Kurtoglu S. Post-operative subcutaneous fat necrosis in a newborn: a case report. Fetal Pediatr Pathol 2011; 30 (6) 363-369
• 2 Hicks MJ, Levy ML, Alexander J, Flaitz CM. Subcutaneous fat necrosis of the newborn and hypercalcemia: case report and review of the literature. Pediatr Dermatol 1993; 10 (3) 271-276
• 3 Tran JT, Sheth AP. Complications of subcutaneous fat necrosis of the newborn: a case report and review of the literature. Pediatr Dermatol 2003; 20 (3) 257-261
• 4 Shankaran S, Laptook AR, Ehrenkranz RA , et al; National Institute of Child Health and Human Development Neonatal Research Network. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353 (15) 1574-1584
• 5 Sivanandan S, Rabi Y, Kamaluddeen M, Akierman A, Lodha A. Subcutaneous fat necrosis as a complication of therapeutic hypothermia in a term neonate. Indian J Pediatr 2012; 79 (5) 664-666
• 6 Strohm B, Hobson A, Brocklehurst P, Edwards AD, Azzopardi D ; UK TOBY Cooling Register. Subcutaneous fat necrosis after moderate therapeutic hypothermia in neonates. Pediatrics 2011; 128 (2) e450-e452
• 7 Bonnemains L, Rouleau S, Sing G, Bouderlique C, Coutant R. Severe neonatal hypercalcemia caused by subcutaneous fat necrosis without any apparent cutaneous lesion. Eur J Pediatr 2008; 167 (12) 1459-1461
• 8 Borgia F, De Pasquale L, Cacace C, Meo P, Guarneri C, Cannavo SP. Subcutaneous fat necrosis of the newborn: be aware of hypercalcaemia. J Paediatr Child Health 2006; 42 (5) 316-318
• 9 Katz DA, Huerter C, Bogard P, Braddock SW. Subcutaneous fat necrosis of the newborn. Arch Dermatol 1984; 120 (11) 1517-1518
• 10 Aucharaz KS, Baker EL, Millman GC, Ball RJ. Treatment of hypercalcaemia in subcutaneous fat necrosis is controversial. Horm Res 2007; 68 (1) 31
• 11 Burden AD, Krafchik BR. Subcutaneous fat necrosis of the newborn: a review of 11 cases. Pediatr Dermatol 1999; 16 (5) 384-387
• 12 Caple JI, Reyes S. Subcutaneous fat necrosis of the newborn: a case presentation. J Perinatol 1996; 16 (2 Pt 1) 140-141
• 13 Hakan N, Aydin M, Zenciroglu A , et al. Alendronate for the treatment of hypercalcaemia due to neonatal subcutaneous fat necrosis. Eur J Pediatr 2011; 170 (8) 1085-1086 , author reply 1087
• 14 Lombardi G, Cabano R, Bollani L, Del Forno C, Stronati M. Effectiveness of pamidronate in severe neonatal hypercalcemia caused by subcutaneous fat necrosis: a case report. Eur J Pediatr 2009; 168 (5) 625-627
• 15 Sfaihi L, Kmiha S, Aloulou H, Kamoun T. Biphosphonate therapy in subcutaneous fat necrosis with hypercalcemia and nephrocalcinosis in the newborn. J Neonatal Nurs 2013; 19: 76-79
• 16 Alos N, Eugène D, Fillion M, Powell J, Kokta V, Chabot G. Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis. Horm Res 2006; 65 (6) 289-294
• 17 Dunford JE, Thompson K, Coxon FP , et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 2001; 296 (2) 235-242
• 18 Russell RG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999; 25 (1) 97-106
• 19 Khan N, Licata A, Rogers D. Intravenous bisphosphonate for hypercalcemia accompanying subcutaneous fat necrosis: a novel treatment approach. Clin Pediatr (Phila) 2001; 40 (4) 217-219
• 20 Farooque A, Moss C, Zehnder D, Hewison M, Shaw NJ. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis. Br J Dermatol 2009; 160 (2) 423-425